Results 11 to 17 of about 17 (17)
Качественная клиническая практика, 2018 Chronic obliterating diseases of lower limb arteries is a large group of socially significant diseases, characterized by persistent chronic progress, high probability of disabling complications as well as the emergence needs for expensive surgical ...
A. E. Cheberda +2 more
doaj
Качественная клиническая практика, 2018 Objectives. To evaluate the cost-effectiveness of dapagliflozin in combination with metformin in the treatment T2DM in comparison with glimepiride and sitagliptin also combined with metformin. Methods.
S. K. Zyryanov +3 more
doaj
Pharmacoeconomic evaluation of pramipexole extended release monotherapy in early Parkinson’s disease
Качественная клиническая практика, 2018 Objective. Health economic expertise of pramipexole extended release monotherapy at early stages of Parkinson’s disease. Methods. An economic model was developed based on clinical studies to derive comparative information on the effectiveness, utility ...
D. Yu. Belousov, E. V. Afanasyeva
doaj
Pharmacoeconomic analysis of Cocarnit® complex as treatment for diabetic polyneuropathy
Качественная клиническая практика, 2018 Diabetic polyneuropathy (DP) occupies the third place among the most common neurological disorders, affecting a significant portion of diabetes patients, and is characterized by progressive lesions of nervous fibers.
D. Yu. Belousov, A. E. Cheberda
doaj
Assessment of the economic efficiency of the anesthetic nefopam in therapy postoperative pain
Качественная клиническая практика, 2018 The purpose of this pharmacoeconomic analysis was to determine the drug Nefopam economic feasibility of its use for postoperative pain relief in terms of the health system of the Russian Federation.
D. Yu. Belousov +2 more
doaj
Качественная клиническая практика, 2018 We aimed to conduct cost-utility analysis of two different regimens of the oral hypoglycemic therapy in 2 type diabetes mellitus (DM2). Methods. In the whole, 229 patients with DM2, receiving vildagliptin add-on to metformin (group 1) or sulphonylureas ...
T. I. Ionova +3 more
doaj
Peri-operative pulse oximetry in low-income countries: a cost-effectiveness analysis. [PDF]
Bull World Health Organ, 2014 Burn SL +3 more
europepmc +1 more source